Suppr超能文献

Fontan手术后单心室患者的心外膜起搏器植入及随访

Epicardial pacemaker implantation and follow-up in patients with a single ventricle after the Fontan operation.

作者信息

Cohen M I, Vetter V L, Wernovsky G, Bush D M, Gaynor J W, Iyer V R, Spray T L, Tanel R E, Rhodes L A

机构信息

Divisions of Cardiology and Cardiothoracic Surgery, The Children's Hospital of Philadelphia, 34th and Civic Center Boulevard, Philadelphia, PA 19104, USA.

出版信息

J Thorac Cardiovasc Surg. 2001 Apr;121(4):804-11. doi: 10.1067/mtc.2001.113027.

Abstract

OBJECTIVES

There is an increasing incidence of sinus node dysfunction after the Fontan procedure. Inability to maintain atrioventricular synchrony after the Fontan operation has been associated with an adverse late outcome. Although pacing may be helpful as a primary or adjunct modality after the Fontan procedure, the effects of performing a late thoracotomy or sternotomy for epicardial pacemaker implantation are unknown. In addition, little is known about the long-term effectiveness of epicardial leads in patients with single ventricles. The purpose of this study was to compare the hospital course and follow-up of epicardial pacing lead implantation in patients with Fontan physiology and patients with 2-ventricle physiology.

METHODS

We retrospectively reviewed all isolated epicardial pacemaker implantations and outpatient evaluations performed between January 1983 and June 2000.

RESULTS

There was no difference in the perioperative course for the 31 Fontan patients (27 atrial and 41 ventricular leads [68 total]) compared with the 56 non-Fontan subjects (9 atrial and 61 ventricular leads [70 total]). The median length of stay in Fontan and non-Fontan patients was 3 and 4 days, respectively. There was no early mortality in either group. Pleural drainage for 5 days or longer was reported in 4% of the Fontan cohort and 3% of the non-Fontan group. Late pleural effusions were identified in only 2 patients in the Fontan group and 2 patients in the non-Fontan group. There was no significant difference in epicardial lead survival between the Fontan group and the non-Fontan group (1 year, 96%; 2 years, 90%; 5 years, 70%). The overall incidence of lead failure was 17% (24/138).

CONCLUSIONS

Epicardial leads can be safely placed in Fontan patients at no additional risk compared to patients with biventricular physiology. Sensing and pacing qualities were relatively constant in both the Fontan and non-Fontan groups over the first 2 years after implantation.

摘要

目的

在Fontan手术之后,窦房结功能障碍的发生率日益增加。Fontan手术后无法维持房室同步与不良的晚期结局相关。尽管起搏作为Fontan手术后的主要或辅助方式可能有益,但晚期开胸或胸骨切开术用于植入心外膜起搏器的效果尚不清楚。此外,对于单心室患者心外膜导线的长期有效性知之甚少。本研究的目的是比较Fontan循环生理患者和双心室生理患者在心外膜起搏导线植入后的住院过程及随访情况。

方法

我们回顾性分析了1983年1月至2000年6月期间所有单独的心外膜起搏器植入及门诊评估情况。

结果

31例Fontan患者(27根心房导线和41根心室导线[共68根])与56例非Fontan受试者(9根心房导线和61根心室导线[共70根])的围手术期过程并无差异。Fontan患者和非Fontan患者的中位住院时间分别为3天和4天。两组均无早期死亡病例。Fontan队列中有4%的患者和非Fontan组中有3%的患者报告胸腔引流持续5天或更长时间。Fontan组和非Fontan组中均仅有2例患者出现晚期胸腔积液。Fontan组和非Fontan组的心外膜导线存活率无显著差异(1年,96%;2年,90%;5年,70%)。导线故障的总体发生率为17%(24/138)。

结论

与双心室生理患者相比,Fontan患者可安全植入心外膜导线,且无额外风险。在植入后的前2年,Fontan组和非Fontan组的感知和起搏质量相对稳定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验